Abstract
BackgroundT-cell engagers (TCEs) have established their therapeutic value in treatment of various cancers by harnessing the power of immune system against tumors in a targeted manner. IgM based TCEs may...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
